ArriVent BioPharmaAVBP
那斯達克 · USD
18.62
+0.60
(+3.33%)
收盤 08/15 03:59 (UTC+8)
08/15 03:59 (UTC+8)
ArriVent BioPharmaAVBP
18.62
+0.60
(+3.33%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- -
- -
- -
- -
- -
- -
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 0 | - | - | - | - | - | - | 0 | 0 | 0 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 0 | - | - | - | - | - | - | 0 | 0 | 0 |
營業費用 | 33,623 | 66,772 | - | - | - | - | 23,118 | 16,716 | 22,584 | 12,172 |
研發費用 | 27,720 | 61,289 | 20,163 | 20,088 | 21,778 | 16,975 | 20,010 | 14,280 | 20,358 | 10,236 |
推銷及管理費用 | 5,903 | 5,483 | 3,542 | 4,144 | 3,919 | 3,699 | 3,108 | 2,436 | 2,226 | 1,936 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -33,623 | -66,772 | -23,705 | -24,232 | -25,697 | -20,674 | -23,118 | -16,716 | -22,584 | -12,172 |
其他收入及費用 | - | 2,385 | 3,072 | 3,668 | 3,823 | 3,257 | 1,925 | - | - | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -31,399 | -64,387 | -20,633 | -20,564 | -21,874 | -17,417 | -21,193 | -14,401 | -21,567 | -12,172 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -31,399 | -64,387 | -20,633 | -20,564 | -21,874 | -17,417 | -21,193 | -14,401 | -21,567 | -12,172 |
基本每股稅後盈餘(元) | -0.90 | -1.90 | -0.60 | -0.61 | -0.65 | -0.70 | - | -0.45 | -0.67 | -0.38 |
稀釋每股稅後盈餘(元) | -0.90 | -1.90 | -0.61 | -0.61 | -0.64 | -0.70 | -7.69 | -0.45 | -0.67 | -0.38 |
基本平均股數(千股) | 35006.00 | 33898.00 | 33748.00 | 33581.00 | 33502.00 | 25046.00 | - | 31956.00 | 31956.00 | 31956.00 |
稀釋平均股數(千股) | 35006.00 | 33898.00 | 33748.00 | 33581.00 | 33502.00 | 25046.00 | - | 31956.00 | 31956.00 | 31956.00 |
還原基本每股稅後盈餘(元) | -0.90 | -1.90 | -0.60 | -0.61 | -0.65 | -0.70 | - | -0.45 | -0.67 | -0.38 |
還原稀釋每股稅後盈餘(元) | -0.90 | -1.90 | -0.61 | -0.61 | -0.64 | -0.70 | -7.69 | -0.45 | -0.67 | -0.38 |
還原基本平均股數(千股) | 35,006 | 33,898 | 33,748 | 33,581 | 33,502 | 25,046 | - | 31,956 | 31,956 | 31,956 |
還原稀釋平均股數(千股) | 35,006 | 33,898 | 33,748 | 33,581 | 33,502 | 25,046 | - | 31,956 | 31,956 | 31,956 |
EBITDA(千元) | -31,399 | -64,387 | -20,633 | -20,564 | -21,874 | -17,417 | -21,193 | -14,401 | -21,567 | -12,172 |